Immune low-response states significantly impact the effectiveness of immunotherapy in cancer treatment. These states ...

This article explores how single-cell multiomics and spatial transcriptomics are illuminating early pregnancy, uncovering ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression sustained improvement in kidney ...

Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...

Scientists at the Wellcome Sanger Institute and EMBL’s European Bioinformatics Institute (EMBL-EBI) in Hinxton mapped the ...

Your liver cells are forgetting how to do their jobs under dietary stress. Here's how that signals cancer risk years before ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

A research group has developed a novel and highly accessible technology for producing uniform biomolecular condensates using ...

Festive favorites of the holiday season, reindeer possess remarkable genomic adaptations that allow them to thrive in the ...

A new imaging technology can distinguish cancerous tissue from healthy cells by detecting ultra-weak light signals. It relies ...